What is the Inovio Pharmaceuticals Inc (INO) price today?

The price of Inovio Pharmaceuticals Inc (INO) today is $1.47. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/INO

Buy & Sell Inovio Pharmaceuticals Inc (INO) – Inovio Pharmaceuticals Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

INO trades at $1.745, up 4.49% today, with a bullish technical signal from moving averages. The company shows no revenue growth, with 2024 revenue of $217.76K and a net loss of $107.25M, resulting in negative profit margins and returns. Recent earnings beats have occurred, but a securities fraud class action lawsuit filed by multiple law firms (GlobeNewsWire, PRNewsWire, Newsfile Corp, March 2026) adds significant legal overhang.

The outlook remains highly speculative. Analyst consensus is mixed with 53% buy ratings, but fundamental weakness and ongoing litigation pose substantial risks. Investment potential hinges on future clinical successes, yet current financials and legal challenges present a cautious scenario for stockholders.

Read full analysis

Key Stats

Market Cap
$120.22M
Sector
Health
3M Drawdown
-18.52%
Enterprise Value
$71.08M
Dividend Yield
-
Trading Activity
0% Buy | 100% Sell
Typical Hold Time
41 days

$1.47

52W Low: $1.31

15 Jul 2025

52W High: $2.87

08 Sep 2025

Inovio Pharmaceuticals Inc (INO) is currently valued at a market capitalization of $120.22M, with an enterprise value of $71.08M. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $1.31 and a high of $2.87, highlighting its annual price range. Over the past three months, Inovio Pharmaceuticals Inc has recorded a drawdown of -18.52%, reflecting recent price volatility. Inovio Pharmaceuticals Inc offers a dividend yield of -. On average, investors hold Inovio Pharmaceuticals Inc for approximately 41 days, indicating typical investor behavior on the platform.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Technical Indicators

Overall Summary

Bearish (5)Neutral (4)Bullish (18)

News

Globe Newswire9 day ago

Levi & Korsinsky, LLP: Fraud-On-The-Market Doctrine Underpins Inovio Pharmaceuticals Securities Class Action

Globe Newswire11 day ago

INO FINAL DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

Globe Newswire13 day ago

Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Globe Newswire14 day ago

INO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

Globe Newswire15 day ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Richtech Robotics Inc. of Class Action Lawsuit and Upcoming Deadlines – RR

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$120.22M
Sector
Health
3M Drawdown
-18.52%
Enterprise Value
$71.08M
Dividend Yield
-
Trading Activity
0% Buy | 100% Sell
Typical Hold Time
41 days

$1.47

52W Low: $1.31

15 Jul 2025

52W High: $2.87

08 Sep 2025

Let’s invest in this asset by signing up or download!

Buy & Sell Inovio Pharmaceuticals Inc (INO) – Inovio Pharmaceuticals Inc Price Today

Aura AI Summary

Key Stats

About Inovio Pharmaceuticals Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store